pubmed-article:2473969 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C0006754 | lld:lifeskim |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C0018591 | lld:lifeskim |
pubmed-article:2473969 | lifeskim:mentions | umls-concept:C1710133 | lld:lifeskim |
pubmed-article:2473969 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:2473969 | pubmed:dateCreated | 1989-8-29 | lld:pubmed |
pubmed-article:2473969 | pubmed:abstractText | The beta-gene-cluster haplotype and alpha-gene status were determined for 221 patients with sickle cell anemia, 41 with SC disease, and 21 with S-beta-thalassemia. Among SS patients, eleven beta S haplotypes were found in 21 combinations. Three haplotypes--the Benin (Ben) [---+-], the Central African Republic (CAR) [+---+], and the Senegal (Sen) [+- ]--comprise 61%, 21%, and 10% of the chromosomes, respectively. Cleavage at the Xmn I site 5' to the G gamma gene was observed only when the Senegalese arrangement was present. The linear correlation which exists between the absolute value of the G gamma chains and the Hb F for each haplotype combination suggests a feed-back mechanism which controls the G gamma to A gamma ratio and thus the Hb F level (or vice versa). The A gamma T chain was present with specific haplotypes [++-++] and [++-+-]. Heterozygous or homozygous alpha-thalassemia-2 was present in 36% of the SS patients and was randomly distributed among beta S-gene-cluster haplotypes. The variable levels of hemoglobin, MCV, Hb F, G gamma chains, and Hb A2 are in response to the heterogeneous genetic mix of the beta S-gene-cluster haplotypes and alpha-thalassemia-2 in American patients with sickle cell anemia. The influence of alpha-thalassemia-2 on the level of Hb F is dependent on the beta S-cluster haplotype. Hb A2 levels increased with decrease in the number of alpha genes. Among SC and S-beta-thalassemia patients the beta-cluster polymorphisms on the beta S chromosome were those commonly associated with the African origins of beta S haplotype. The haplotype [+--+-] was present on the C chromosome in 90% of the cases. Most beta-thalassemia chromosomes had haplotypes that matched the common African polymorphisms. An alpha-gene deletion was found in 29% of the SC and S-beta-thalassemia patients. | lld:pubmed |
pubmed-article:2473969 | pubmed:language | eng | lld:pubmed |
pubmed-article:2473969 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2473969 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2473969 | pubmed:issn | 0363-0269 | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:SchroederW... | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:SheltonJ BJB | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:SheltonJ RJR | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:PowarsD RDR | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:KayL MLM | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:ChanL SLS | lld:pubmed |
pubmed-article:2473969 | pubmed:author | pubmed-author:HuynhVV | lld:pubmed |
pubmed-article:2473969 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2473969 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:2473969 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2473969 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2473969 | pubmed:pagination | 325-53 | lld:pubmed |
pubmed-article:2473969 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:meshHeading | pubmed-meshheading:2473969-... | lld:pubmed |
pubmed-article:2473969 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2473969 | pubmed:articleTitle | Beta-cluster haplotypes, alpha-gene status, and hematological data from SS, SC, and S-beta-thalassemia patients in southern California. | lld:pubmed |
pubmed-article:2473969 | pubmed:affiliation | Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena 91125. | lld:pubmed |
pubmed-article:2473969 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2473969 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2473969 | lld:pubmed |